A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Mechlorethamine
Etifoxine
The risk or severity of adverse effects can be increased when Pancuronium is combined with Etifoxine.
Mechlorethamine
Ifenprodil
The risk or severity of adverse effects can be increased when Pancuronium is combined with Ifenprodil.
Mechlorethamine
Amperozide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Amperozide.
Mechlorethamine
Perospirone
The risk or severity of adverse effects can be increased when Pancuronium is combined with Perospirone.
Mechlorethamine
Pomalidomide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Pomalidomide.
Mechlorethamine
Arbaclofen Placarbil
The risk or severity of adverse effects can be increased when Pancuronium is combined with Arbaclofen Placarbil.
Mechlorethamine
Gabapentin enacarbil
The risk or severity of adverse effects can be increased when Pancuronium is combined with Gabapentin enacarbil.
Mechlorethamine
Serotonin
The risk or severity of adverse effects can be increased when Pancuronium is combined with Serotonin.
Mechlorethamine
Lurasidone
The risk or severity of adverse effects can be increased when Pancuronium is combined with Lurasidone.
Mechlorethamine
Tofisopam
The risk or severity of adverse effects can be increased when Pancuronium is combined with Tofisopam.
Mechlorethamine
Cinitapride
The risk or severity of adverse effects can be increased when Pancuronium is combined with Cinitapride.
Mechlorethamine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when Pancuronium is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Mechlorethamine
Sulthiame
The risk or severity of adverse effects can be increased when Pancuronium is combined with Sulthiame.
Mechlorethamine
Wortmannin
The risk or severity of adverse effects can be increased when Pancuronium is combined with Wortmannin.
Mechlorethamine
Mebutamate
The risk or severity of adverse effects can be increased when Pancuronium is combined with Mebutamate.
Mechlorethamine
Benzyl alcohol
The risk or severity of adverse effects can be increased when Pancuronium is combined with Benzyl alcohol.
Mechlorethamine
Triclofos
The risk or severity of adverse effects can be increased when Pancuronium is combined with Triclofos.
Mechlorethamine
Fospropofol
The risk or severity of adverse effects can be increased when Pancuronium is combined with Fospropofol.
Mechlorethamine
Dexmethylphenidate
The risk or severity of adverse effects can be increased when Pancuronium is combined with Dexmethylphenidate.
Mechlorethamine
Nitrous oxide
The risk or severity of adverse effects can be increased when Pancuronium is combined with Nitrous oxide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3